Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Octreotide Counteracts IFN-γ-Induced Endothelial Inflammation.

Journal of biochemical and molecular toxicology·2026

Same author

Ceapin-A7 counteracts the protective effects of Lanreotide in endothelial cells.

Aspects of molecular medicine·2026

Same author

Never in Mitosis Gene A-Related Kinase Inhibition Alleviates Inflammation in an In Vivo Model of Acute Lung Injury.

Cell biology international·2025

Same author

Somatostatin analogs in endothelial dysfunction.

American journal of physiology. Endocrinology and metabolism·2025

Same author

Lanreotide in endothelial corneal inflammation.

Hormones (Athens, Greece)·2025

Same author

ATF6 inhibition suppresses the protective effects of pasireotide in human and bovine endothelial cells.

Vascular biology (Bristol, England)·2025

Same journal

Affinity of Abelmoschus Esculentus Lectin for the Midpiece of Ovine Spermatozoa and Its Effects on Functional Parameters.

Cell biochemistry and function·2026

Same journal

Tracking the Trail of Monkeypox: From Origins to Outbreak Control.

Cell biochemistry and function·2026

Same journal

Anticancer Therapeutic Potential of Mitochondria-Targeted Antioxidants Against N-Nitrosodiethylamine-Induced Hepatocarcinogenesis.

Cell biochemistry and function·2026

Same journal

ATP Hydrolysis Gates an Ultra-Rapid Unwinding Mode of AfXPB Revealed by DNA Electrochemistry.

Cell biochemistry and function·2026

Same journal

Targeted Micronutrient Supplementation in Diabetic Retinopathy With MTHFR Polymorphisms: Biomarker Shifts and Clinical Uncertainty.

Cell biochemistry and function·2026

Same journal

Biomimetic Shell-Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer.

Cell biochemistry and function·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Insights on Endothelial Injury.

Nektarios Barabutis¹

¹School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, Louisiana, USA.

Cell Biochemistry and Function

|June 23, 2026

Summary

This summary is machine-generated.

This study reviews new drug therapies for severe diseases like sepsis and lung injury. It focuses on treatments targeting endothelial barrier dysfunction, a key feature of these conditions.

More Related Videos

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

Related Experiment Videos

Last Updated: Jun 24, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

Area of Science:

Biomedical Science
Pharmacology
Pathophysiology

Background:

Endothelial barrier dysfunction is a critical factor in severe diseases such as sepsis and acute lung injury.
Understanding the mechanisms of endothelial dysfunction is crucial for developing effective treatments.

Purpose of the Study:

To summarize recent advancements in pharmacotherapies for endothelium-dependent disorders.
To highlight novel findings in the development of treatments for endothelial barrier dysfunction.

Main Methods:

Literature review of recent scientific publications.
Analysis of preclinical and clinical studies on pharmacotherapies.
Synthesis of current research on endothelial barrier function.

Main Results:

Identification of emerging drug targets for endothelial dysfunction.
Overview of promising therapeutic strategies currently under investigation.
Summary of key findings from recent studies in the field.

Conclusions:

Pharmacotherapies targeting endothelial barrier dysfunction show significant potential for treating severe diseases.
Continued research is essential to translate these findings into clinical practice.
Novel therapeutic approaches are emerging to combat endothelium-dependent disorders.